Center for Vaccine Innovation and Access
PATH
Mark Alderson, PhD, MBA, Center for Vaccine Innovation and Access, PATH (Seattle, USA) Dr. Alderson is the Bacterial Vaccine Initiative Leader with PATH’s Center for Vaccine Innovation and Access, playing a lead role in the Pneumococcal Vaccine Project (PVP), Group B Streptococcal (GBS) Vaccine Project and Meningococcal Vaccine Project, Polyvalent (MVPP). These projects seek to accelerate the development and licensure of promising pneumococcal, GBS and meningococcal vaccines and ensure their availability and use in developing countries. Dr. Alderson led the PATH team that worked in close collaboration with the Serum Institute of India to develop, license and WHO prequalify the 10-valent pneumococcal conjugate vaccine, PNEUMOSIL, in 2019. Dr. Alderson has more than 30 years of experience in medical research, biotechnology, pharmaceuticals and vaccine development. He joined PATH in August, 2006, serving initially as PVP Scientific Director until his appointment as PVP Director in July, 2007. He was appointed MVPP director in 2012 and GBS Vaccine Project Director in 2016. Prior to joining PATH, Dr. Alderson was Director of Immunology at GlaxoSmithKline Biologicals, Seattle, where he led preclinical work on synthetic adjuvants for a variety of vaccine targets. Prior to GSK, he was Senior Director of Immunology at Corixa Corporation where he was responsible for the preclinical discovery and evaluation of adjuvants and vaccines for tuberculosis, Chlamydia and HSV. Dr. Alderson has published over 100 manuscripts in peer reviewed journals. He served as an Affiliate Associate Professor, Department of Pathobiology at the University of Washington from 2002 until 2006. Dr. Alderson earned his PhD in immunology at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia and his MBA at Seattle University, USA.

Presenter of 1 Presentation

Lower Cost PCV: PNEUMOSIL

Session Type
Special Symposium
Date
Mon, 21.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Session Icon
Live Session
Lecture Time
11:05 AM - 11:28 AM